CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTH CARE RESOURCE UTILIZATION IN UNRESECTABLE, LOCALLY ADVANCED, STAGE III NON-SMALL CELL LUNG CANCER: A MEDICAL RECORD REVIEW STUDY IN THE UNITED STATES AND CANADA

被引：1
|
作者：
Kurosky, S. [1 ]
Klein, A. B. [2 ]
Parikh, R. C. [1 ]
Trantham, L. [1 ]
Zhang, Y. [2 ]
Levine, C. A. [1 ]
Kaye, J. A. [3 ]
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] AstraZeneca, Gaithersburg, MD USA
[3] RTI Hlth Solut, Waltham, MA USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.286
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN239
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [1] UNRESECTABLE, LOCALLY ADVANCED, STAGE III NON-SMALL CELL LUNG CANCER: REAL-WORLD CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTH CARE RESOURCE UTILIZATION IN EUROPE
    Trantham, L.
    Klein, A. B.
    Parikh, R. C.
    Kurosky, S.
    Zhang, Y.
    Levine, C. A.
    Kaye, J. A.
    VALUE IN HEALTH, 2018, 21 : S49 - S49
  • [2] Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancer
    Rigas, JR
    Lara, PN
    LUNG CANCER, 2005, 50 : S17 - S24
  • [3] Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer
    Anna Hung
    Kyung Min Lee
    Julie A. Lynch
    Yanhong Li
    Pradeep Poonnen
    Olga V. Efimova
    Bradley J. Hintze
    Trudy Buckingham
    Candice Yong
    Brian Seal
    Michael J. Kelley
    Shelby D. Reed
    BMC Cancer, 21
  • [4] Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer
    Hung, Anna
    Lee, Kyung Min
    Lynch, Julie A.
    Li, Yanhong
    Poonnen, Pradeep
    Efimova, Olga V.
    Hintze, Bradley J.
    Buckingham, Trudy
    Yong, Candice
    Seal, Brian
    Kelley, Michael J.
    Reed, Shelby D.
    BMC CANCER, 2021, 21 (01)
  • [5] STAGE III UNRESECTABLE NON-SMALL CELL LUNG CANCER TREATMENT PATTERNS AND COSTS: AN ONTARIO, CANADA ANALYSIS
    Seung, S. J.
    Hurry, M.
    Walton, R. N.
    Evans, W. K.
    VALUE IN HEALTH, 2018, 21 : S51 - S52
  • [6] Utilization of PET Scan in Advanced Stage Non-Small Cell Lung Cancer in the United States
    Behera, M.
    Jiang, R.
    Higgins, K.
    Pillai, R.
    Owonikoko, T.
    Belani, C.
    Khuri, F.
    Ward, K.
    Curran, W., Jr.
    Ramalingam, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2325 - S2326
  • [7] Optimal Treatment of Unresectable Stage III Non-Small Cell Lung Cancer
    Bradley, Jeffrey D.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (11) : 853 - 855
  • [8] Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancer
    Cheema, P. K.
    Rothenstein, J.
    Melosky, B.
    Brade, A.
    Hirsh, V.
    CURRENT ONCOLOGY, 2019, 26 (01) : 37 - 42
  • [9] Locally advanced, unresectable non-small cell lung cancer - New treatment strategies
    Johnson, DH
    CHEST, 2000, 117 (04) : 123S - 126S
  • [10] COAST: Durvalumab Alone or with Novel Agents for Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer
    Herbst, R.
    Barlesi, F.
    Paz-Ares, L.
    Raben, D.
    Aggarwal, C.
    Bothos, J.
    Samadani, R.
    He, P.
    Angra, N.
    Martinez, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S450 - S451
12345